Delivery Order SPE2DB20D1004-SPE2DB23FE8F4
- Not listed
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a Firm Fixed Price Delivery Order with a completion date of March 2, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $15,088.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a pharmaceutical product used for the treatment of diabetes. The contract has an ultimate completion date of April 25, 2023 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program, indicating it was...
- This federal contract award, valued at $3,110.44, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 19, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,161.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,253.86 firm fixed-price delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,046.24 with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as the prime contractor. The contract is for the supply of Trulicity 4.5 mg/0.5 ml pens, a medication used to manage diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $2,248.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used for diabetes management. This is a firm fixed-price delivery order contract with an ultimate completion date of January 10, 2022. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $17,832.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a pharmaceutical product used for the treatment of diabetes. This is a firm-fixed-price delivery order contract with a completion date of May 16, 2023. The contract was awarded through full and open competition, with no set-aside designation....
- This federal contract award, valued at $1,299.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in supplying pharmaceutical products and medical supplies to federal government agencies, particularly the Department of...
- This federal contract award, valued at $2,898.06, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a type of injectable medication used to treat diabetes. This delivery order has an ultimate completion date of November 9, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FE8F4Delivery Order
This federal contract award, valued at $1,161.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of November 4, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/3/22 |